![](/img/cover-not-exists.png)
DARING-B: discontinuation of effective entecavir or tenofovir disoproxil fumarate long-term therapy before HBsAg loss in non-cirrhotic HBeAg-negative chronic hepatitis B
Papatheodoridis, George V, Rigopoulou, Eirini I, Papatheodoridi, Margarita, Zachou, Kalliopi, Xourafas, Vassilios, Gatselis, Nikolaos, Hadziyannis, Emilia, Vlachogiannakos, John, Manolakopoulos, SpiliYear:
2018
Language:
english
Journal:
Antiviral therapy
DOI:
10.3851/IMP3256
File:
PDF, 359 KB
english, 2018